The role of human milk immunomodulators in protecting against viral bronchiolitis and development of chronic wheezing illness

Children

Volumn 2, Issue 3, 2015, Pages 289-304

  Dixon, Dani Louise ^a,b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Breastfeeding; Bronchiolitis; Cytokines; Leukocytes; RSV; Viruses

Indexed keywords

EID: 85009365262     PISSN: None     EISSN: 22279067     Source Type: Journal    
DOI: 10.3390/children2030289     Document Type: Review

References (102)

1. Holt, P.G.; McMenamin, C.; Nelson, D. Primary sensitisation to inhalant allergens during infancy. Pediatr. Allergy Immunol. 1990, 1, 3–13.
2. Erb, K.J. Atopic disorders: A default pathway in the absence of infection? Immunol. Today 1999, 20, 317–322.
3. Bjorksten, B. Environmental influence on the development of childhood immunity. Nutr. Rev. 1998, 56, S106–S112.
4. Hamilton, G. Let them eat dirt. New Sci. 1998, 159, 26–31.
5. Folkerts, G.; Walzl, G.; Openshaw, P.J. Do common childhood infections ‘teach’ the immune system not to be allergic? Immunol. Today 2000, 21, 118–120.
6. Rook, G.A.; Brunet, L.R. Give us this day our daily germs. Biologist 2002, 49, 145–149.
7. Goldman, A.S.; Chheda, S.; Garofalo, R. Spectrum of immunomodulating agents in human milk. Int. J. Pediatr. Hematol. Oncol. 1997, 4, 491–497.
8. Marzi, M.; Vigano, A.; Trabattoni, D.; Villa, M.L.; Salvaggio, A.; Clerici, E.; Clerici, M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 1996, 106, 127–133.
9. Moraes-Pinto, M.I.; Vince, G.S.; Flanagan, B.F.; Hart, C.A.; Johnson, P.M. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology 1997, 90, 87–94.
10. Asher, I.; Boner, A.; Chuchalin, A.; Custovic, A.; Dagli, E.; Haus, M.; Hemmo-Lotem, M.; Holgate, S.T.; Holt, P.G.; Høst, A.; et al. Prevention of allergy and asthma: Interim report. Allergy 2000, 55, 1069–1088.
11. Rautava, S.; Walker, W.A. Academy of Breastfeeding Medicine founder’s lecture 2008: Breastfeeding—An extrauterine link between mother and child. Breastfeed. Med. 2009, 4, 3–10.
12. Jones, C.A.; Warner, J.A.; Warner, J.O. Fetal swallowing of IgE. Lancet 1998, 351, 1859.
13. Hayward, A.R.; Ezer, G. Development of lymphocyte populations in the human foetal thymus and spleen. Clin. Exp. Immunol. 1974, 17, 169–178.
14. Toivanen, P.; Asantila, T.; Granberg, C.; Leino, A.; Hirvonen, T. Development T cell repertoire in the human and the sheep fetus. Immunol. Rev. 1978, 42, 185–201.
15. Miller, D.L.; Hiravonen, T.; Gitlin, D. Synthesis of IgE by the human conceptus. J. Allergy Clin. Immunol. 1973, 52, 182–188.
16. Liao, S.Y.; Liao, T.N.; Chiang; B.L.; Huang, M.S.; Chen, C.C.; Chou, C.C.; Hsieh, K.H. Decreased production of IFN gamma and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin. Exp. Allergy 1996, 26, 397–405.
17. Warner, J.O.; Warner, J.A.; Miles, E.A.; Jones, A.C. Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 1994, 344, 983–985.
18. Verduci, E.; Banderali, G.; Barberi, S.; Radaelli, G.; Lops, A.; Betti, F.; Riva, E.; Giovannini, M. Epigenetic effects of human breast milk. Nutrients 2014, 6, 1711–1724.
19. Kosaka, N.; Izumi, H.; Sekine, K.; Ochiya, T. microRNA as a new immune-regulatory agent in breast milk. Silence 2010, 1, doi:10.1186/1758-907X-1-7.
20. Infante-Rivard, C.; Amre, D.; Gautrin, D.; Malo, J.L. Family size, day-care attendance, and breastfeeding in relation to the incidence of childhood asthma. Am. J. Epidemiol. 2001, 153, 653– 658.
21. Ball, T.M.; Holberg, C.J.; Aldous, M.B.; Martinez, F.D.; Wright, A.L. Influence of attendance at day care on the common cold from birth through 13 years of age. Arch. Pediatr. Adolesc. Med. 2002, 156, 121–126.
22. Montgomery, S.M.; Wakefield, A.J.; Morris, D.L.; Pounder, R.E.; Murch, S.H. The initial care of newborn infants and subsequent hay fever. Allergy 2000, 55, 916–922.
23. Wahn, U.; von Mutius, E. Childhood risk factors for atopy and the importance of early intervention. J. Allergy Clin. Immunol. 2001, 107, 567–574.
24. Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet, 2001, 357, 1076–1079.
25. Anderson, H.R.; Poloniecki, J.D.; Strachan, D.P.; Beasley, R.; Bjorksten, B.; Asher, M.I. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health 2001, 91, 1126–1129.
26. Shaheen, S.O.; Aaby, P.; Hall, A.J.; Barker, D.J.; Heyes, C.B.; Shiell, A.W.; Goudiaby, A. Measles and atopy in Guinea-Bissau. Lancet 1996, 347, 1792–1796.
27. Shirakawa, T.; Enomoto, T.; Shimazu, S.; Hopkin, J.M. The inverse association between tuberculin responses and atopic disorder. Science 1997, 275, 77–79.
28. Von Mutius, E. Environmental factors influencing the development and progression of pediatric asthma. J. Allergy Clin. Immunol. 2002, 109, S525–S532.
29. Szabo, S.J.; Sullivan, B.M.; Peng, S.L.; Glimcher, L.H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 2003, 21, 713–758.
30. Sigurs, N.; Bjarnason, R.; Sigurbergsson, F.; Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000, 161, 1501–1507.
31. Wang, S.Z.; Forsyth, K.D. Asthma and respiratory syncytial virus infection in infancy: Is there a link? Clin. Exp. Allergy 1998, 28, 927–935.
32. Arribas, J.; Colas, C.; Sebastian, A.; Larraga, R.; Olivares, J.L.; Pastor, I.; Duce, F. Atopy and pulmonary function abnormalities in children with a history of acute bronchiolitis. J. Asthma 2000, 37, 73–80.
33. Sigurs, N.; Bjarnason, R.; Sigurbergsson, F.; Kjellman, B.; Bjorksten, B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics 1995, 95, 500–505.
34. Selnes, A.; Odland, J.O.; Bolle, R.; Holt, J.; Dotterud, L.K.; Lund, E. Asthma and allergy in Russian and Norwegian schoolchildren: Results from two questionnaire-based studies in the Kola Peninsula, Russia, and northern Norway. Allergy 2001, 56, 344–348.
35. Shamssain, M.H.; Shamsian, N. Prevalence and severity of asthma, rhinitis, and atopic eczema in 13-to 14-year-old schoolchildren from the northeast of England. Ann. Allergy Asthma Immunol. 2001, 86, 428–432.
36. Kuehni, C.E.; Davis, A.; Brooke, A.M.; Silverman, M. Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet 2001, 357, 1821–1825.
37. Downs, S.H.; Marks, G.B.; Sporik, R.; Belosouva, E.G.; Car, N.G.; Peat, J.K. Continued increase in the prevalence of asthma and atopy. Arch. Dis. Child. 2001, 84, 20–23.
38. Selnes, A.; Bolle, R.; Holt, J.; Lund, E. Cumulative incidence of asthma and allergy in north-Norwegian schoolchildren in 1985 and 1995. Pediatr. Allergy Immunol. 2002, 13, 58–63.
39. Wang, S.Z.; Xu, H.; Wraith, A.; Bowden, J.J.; Alpers, J.H.; Forsyth, K.D. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur. Respir. J. 1998, 12, 612–618.
40. Harrison, A.M.; Bonville, C.A.; Rosenberg, H.F.; Domachowske, J.B. Respiratory syncytical virus-induced chemokine expression in the lower airways—Eosinophil recruitment and degranulation. Am. J. Respir. Crit. Care Med. 1999, 159, 1918–1924.
41. Garofalo, R.P.; Patti, J.; Hintz, K.A.; Hill, V.; Ogra, P.L.; Welliver, R.C. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2001, 184, 393–399.
42. Smith, P.K.; Wang, S.Z.; Dowling, K.D.; Forsyth, K.D. Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J. Paediatr. Child Health 2001, 37, 146–151.
43. Bataki, E.L.; Evans, G.S.; Everard, M.L. Respiratory syncytial virus and neutrophil activation. Clin. Exp. Immunol. 2005, 140, 470–477.
44. Folkerts, G.; Busse, W.W.; Nijkamp, F.P.; Sorkness, R.; Gern, J.E. Virus-induced airway hyperresponsiveness and asthma. Am. J. Respir. Crit Care Med. 1998, 157, 1708–1720.
45. Simoes, E.A. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J. Pediatr. 2003, 143, S118–S126.
46. Koehoorn, M.; Karr, C.J.; Demers, P.A.; Lencar, C.; Tamburic, L.; Brauer, M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics 2008, 122, 1196–1203.
47. Alwan, W.H.; Record, F.M.; Openshaw, P.J. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin. Exp. Immunol. 1992, 88, 527–536.
48. Roman, M.; Calhoun, W.J.; Hinton, K.L.; Avendaño, L.F.; Simon, V.; Escobar, A.M.; Gaggero, A.; Díaz, P.V. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 1997, 156, 190–195.
49. Renzi, P.M.; Turgeon, J.P.; Marcotte, J.E.; Drblik, S.P.; Bérubé, D.; Gagnon, M.F.; Spier, S. Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am. J. Respir. Crit. Care Med. 1999, 159, 1417–1422.
50. Schwarze, J.; Makela, M.; Cieslewicz, G.; Dakhama, A.; Lahn, M.; Ikemura, T.; Joetham, A.; Gelfand, E.W. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J. Immunol. 1999, 163, 5729–5734.
51. De Weerd, W.; Twilhaar, W.N.; Kimpen, J.L. T cell subset analysis in peripheral blood of children with RSV bronchiolitis. Scand. J. Infect. Dis. 1998, 30, 77–80.
52. Tang, Y.W.; Graham, B.S. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Investig. 1997, 99, 2183–2191.
53. Hussell, T.; Baldwin, C.J.; O’Garra, A.; Openshaw, P.J. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 1997, 27, 3341–3349.
54. Hussell, T.; Khan, U.; Openshaw, P. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. J. Immunol. 1997, 159, 328–334.
55. Panuska, J.R.; Merolla, R.; Rebert, N.A.; Hoffmann, S.P.; Tsivitse, P.; Cirino, N.M.; Silverman, R.H.; Rankin, J.A. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin. Investig. 1995, 96, 2445–2453.
56. Flores, P.; Guimarães, J.; Videira Amaral, J.M. Th1 and th2 cytokine expression in nasopharyngeal secretions during acute bronchiolitis in children younger than two years old. Allergol. Immunopathol. 2011, 39, 3–9.
57. Carbonell-Estrany, X.; Fullarton, J.R.; Rodgers-Gray, B.S.; Gooch, K.L.; Vo, P.G.; Figueras-Aloy, J. Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32–35 weeks’ gestational age with more informed use of risk factors? J. Matern. Fetal Neonatal Med. 2014, 14, 1–9.
58. Vereen, S.; Gebretsadik, T.; Hartert, T.V.; Minton, P.; Woodward, K.; Liu, Z.; Carroll, K.N. Association between breast-feeding and severity of acute viral respiratory tract infection. Pediatr. Infect. Dis. J. 2014, 33, 986–988.
59. Ujunwa, F.; Ezeonu, C. Risk factors for acute respiratory tract infections in under-five children in Enugu southeast Nigeria. Ann. Med. Health Sci. Res. 2014, 4, 95–99.
60. Alvarez, A.E.; Marson, F.A.; Bertuzzo, C.S.; Arns, C.W.; Ribeiro, J.D. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J. Pediatr. 2013, 89, 531–543.
61. Bozaykut, A.; Paketci, A.; Sezer, R.G.; Paketci, C. Evaluation of risk factors for recurrent wheezing episodes. J. Clin. Med. Res. 2013, 5, 395–400.
62. Lanari, M.; Prinelli, F.; Adorni, F.; Di Santo, S.; Faldella, G.; Silvestri, M.; Musicco, M.; Italian Neonatology Study Group on RSV Infections. Maternal milk protects infants against bronchiolitis during the first year of life. Results from an Italian cohort of newborns. Early Hum. Dev. 2013, 89, S51–S57.
63. Gut, W.; Pancer, K.; Abramczuk, E.; Cześcik, A.; Dunal-Szczepaniak, M.; Lipka, B.; Litwińska, B. RSV respiratory infection in children under 5 y.o.—Dynamics of the immune response Th1/Th2 and IgE. Przegl. Epidemiol. 2013, 67, 17–22, 105–109.
64. Blanken, M.O.; Koffijberg, H.; Nibbelke, E.E.; Rovers, M.M.; Bont, L.; Dutch RSV Neonatal Network. Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: A multicenter birth cohort study. PLoS ONE 2013, 8, e59161.
65. Sommer, C.; Resch, B.; Simões, E.A. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol. J. 2011, 5, 144–154.
66. Nishimura, T.; Suzue, J.; Kaji, H. Breastfeeding reduces the severity of respiratory syncytial virus infection among young infants: A multi-center prospective study. Pediatr. Int. 2009, 51, 812–816.
67. Dixon, D.L.; Griggs, K.M.; Forsyth, K.D.; Bersten, A.D. Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis. Pediatr. Allergy Immunol. 2010, 21, e691–e696.
68. Roine, I.; Fernandez, J.A.; Vasquez, A.; Caneo, M. Breastfeeding reduces immune activation in primary respiratory syncytial virus infection. Eur. Cytokine Netw. 2005, 16, 206–210.
69. Chiba, Y.; Minagawa, T.; Mito, K.; Nakane, A.; Suga, K.; Honjo, T.; Nakao, T. Effect of breast feeding on responses of systemic interferon and virus-specific lymphocyte transformation in infants with respiratory syncytial virus infection. J. Med. Virol. 1987, 21, 7–14.
70. Wirt, D.P.; Adkins, L.T.; Palkowetz, K.H.; Schmalstieg, F.C.; Goldman, A.S. Activated and memory T lymphocytes in human milk. Cytometry 1992, 13, 282–290.
71. Gibson, C.E.; Eglinton, B.A.; Penttila, I.A.; Cummins, A.G. Phenotype and activation of milk-derived and peripheral blood lymphocytes from normal and coeliac subjects. Immunol. Cell Biol. 1991, 69, 387–393.
72. Sabbaj, S., Ghosh, M.K., Edwards, B.H., Leeth, R., Decker, W.D., Goepfert, P.A., Aldrovandi, G.M. Breast milk-derived antigen-specific CD8+ T cells: An extralymphoid effector memory cell population in humans. J Immunol. 2005, 174, 2951–2956.
73. Bertotto, A.; Gerli, R.; Fabietti, G.; Crupi, S.; Arcangeli, C.; Scalise, F.; Vaccaro, R. Human breast milk T lymphocytes display the phenotype and functional characteristics of memory T cells. Eur. J. Immunol. 1990, 20, 1877–1880.
74. Keller, M.A.; Kidd, R.M.; Bryson, Y.J.; Turner, J.L.; Carter, J. Lymphokine production by human milk lymphocytes. Infect. Immun. 1981, 32, 632–636.
75. Nikolova, E.; Staykova, M.; Raicheva, D.; Karadjova, M.; Neronov, A.; Ivanov, I.; Goranov, I. Interleukin production by human colostral cells after in vitro mitogen stimulation. Am. J. Reprod. Immunol. 1990, 23, 104–106.
76. Bertotto, A.; Castellucci, G.; Radicioni, M.; Bartolucci, M.; Vaccaro, R. CD40 ligand expression on the surface of colostral T cells. Arch. Dis. Child. 1996, 74, F135–F136.
77. Bertotto, A.; Vagliasindi, C.; Gerli, R.; Spinozzi, F.; Castellucci, G.; Fabietti, G.; Crupi, S.; Radicioni, M.; Cozzali, R.; Ferraro, L.; et al. Soluble CD30 antigen in human colostrum. Biol. Neonate 1997, 71, 69–74.
78. Brugnoni, D.; Airo, P.; Graf, D.; Marconiu, M.; Lebowitzu, M.; Plebaniu, A.; Gilianiu, S.; Malacarne1, F.; Cattaneo1, R.; Ugaziou, A.G.; et al. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur. J. Immunol. 1994, 24, 1919–1924.
79. Damen, J.; Regts, J.; Scherphof, G. Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins. Dependence on cholesterol content and phospholipid composition. Biochim. Biophys. Acta 1981, 665, 538–545.
80. Bryan, D.L.; Hart, P.H.; Forsyth, K.D.; Gibson, R.A. Immunomodulatory constituents of human milk change in response to infant bronchiolitis. Pediatr. Allergy Immunol. 2007, 18, 495–502.
81. Lonnerdal, B. Breast milk: A truly functional food. Nutrition 2000, 16, 509–511.
82. Claud, E.C.; Savidge, T.; Walker, W.A. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr. Res. 2003, 53, 419–425.
83. Grazioso, C.F.; Buescher, E.S. Inhibition of neutrophil function by human milk. Cell. Immunol. 1996, 168, 125–132.
84. Mulligan, P.; White, N.R.; Monteleone, G.; Wang, P.; Wilson, J.W.; Ohtsuka, Y.; Sanderson, I.R. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells. Pediatr. Res. 2006, 59, 656–661.
85. Chacon-Cruz, E.; Oelberg, D.G.; Buescher, E.S. Human milk effects on neutrophil calcium metabolism: Blockade of calcium influx after agonist stimulation. Pediatr. Res. 1999, 46, 200–207.
86. Keeney, S.E.; Schmalstieg, F.C.; Palkowetz, K.H.; Rudloff, H.E.; Le, B.M.; Goldman, A.S. Activated neutrophils and neutrophil activators in human milk: Increased expression of CD11b and decreased expression of L-selectin. J. Leukoc. Biol. 1993, 54, 97–104.
87. Vetvicka, V.; Fusek, M. Activation of peripheral blood neutrophils and lymphocytes by human procathepsin D and insulin-like growth factor II. Cell. Immunol. 1994, 156, 332–341.
88. Bode, L.; Rudloff, S.; Kunz, C.; Strobel, S.; Klein, N. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J. Leukoc. Biol. 2004, 76, 820–826.
89. Ichikawa, M.; Sugita, M.; Takahashi, M.; Satomi, M.; Takeshita, T.; Araki, T.; Takahashi, H. Breast milk macrophages spontaneously produce granulocyte-macrophage colony-stimulating factor and differentiate into dendritic cells in the presence of exogenous interleukin-4 alone. Immunology 2003, 108, 189–195.
90. Koning, N.; Kessen, S.F.; van der Voorn, J.P.; Appelmelk, B.J.; Jeurink, P.V.; Knippels, L.M.; Garssen, J.; van Kooyk, Y. Human milk blocks DC-SIGN-pathogen interaction via MUC1. Front. Immunol. 2015, 6, 1–9.
91. Gill, M.A.; Palucka, A.K.; Barton, T.; Ghaffar, F.; Jafri, H.; Banchereau, J.; Ramilo, O. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J. Infect. Dis. 2005, 191, 1105– 1115.
92. Penders, J.; Thijs, C.; Vink, C.; Stelma, F.F.; Snijders, B.; Kummeling, I.; van den Brandt, P.A.; Stobberingh, E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118, 511–521.
93. Azad, M.B.; Konya, T.; Maughan, H.; Guttman, D.S.; Field, C.J.; Chari, R.S.; Sears, M.R.; Becker, A.B.; Scott, J.A.; Kozyrskyj, A.L.; et al. Gut microbiota of healthy Canadian infants: Profiles by mode of delivery and infant diet at 4 months. CMAJ 2013, 185, 385–394.
94. Biesbroek, G.; Bosch, A.A.; Wang, X.; Keijser, B.J.; Veenhoven, R.H.; Sanders, E.A.; Bogaert, D. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am. J. Respir. Crit. Care Med. 2014, 190, 298–308.
95. Laufer, A.S.; Metlay, J.P.; Gent, J.F.; Fennie, K.P.; Kong, Y.; Pettigrew, M.M. Microbial communities of the upper respiratory tract and otitis media in children. MBio. 2011, 2, e00245– 10.
96. Weber, J.A.; Baxter, D.H.; Zhang, S.; Huang, D.Y.; Huang, K.H.; Lee, M.J.; Galas, D.J.; Wang, K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56, 1733–1741.
97. Zhou, Q.; Li, M.; Wang, X.; Li, Q.; Wang, T.; Zhu, Q.; Zhou, X.; Wang, X.; Gao, X.; Li, X. Immune-related microRNAs are abundant in breast milk exosomes. Int. J. Biol. Sci. 2012, 8, 118– 123.
98. Inchley, C.S.; Sonerud, T.; Fjærli, H.O.; Nakstad, B. Nasal mucosal microRNA expression in children with respiratory syncytial virus infection. BMC Infect. Dis. 2015, 15, doi:10.1186/s12879-015-0878-z.
99. Salminen, S.; Isolauri, E. Opportunities for improving the health and nutrition of the human infant by probiotics. Nestle Nutr. Workshop Ser. Pediatr. Program. 2008, 62, 223–233.
100. Bergmann, H.; Rodríguez, J.M.; Salminen, S.; Szajewska, H. Probiotics in human milk and probiotic supplementation in infant nutrition: A workshop report. Br. J. Nutr. 2014, 112, 1119– 1128.
101. Gueimonde, M.; Sakata, S.; Kalliomäki, M.; Isolauri, E.; Benno, Y.; Salminen, S. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J. Pediatr. Gastroenterol. Nutr. 2006, 42, 166–170.
102. Grönlund, M.M.; Gueimonde, M.; Laitinen, K.; Kociubinski, G.; Grönroos, T.; Salminen, S.; Isolauri, E. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin. Exp. Allergy 2007, 37, 1764–1772.